| Mass | 10MG |
|---|
Secretagogue Research
Ipamorelin
Ipamorelin is a synthetic pentapeptide (CAS 170851-70-4), supplied as a lyophilised research peptide.
Lot report pending · Lab report library
MASS
QUANTITY
1
$54.99
BUY ONE, GET ONE FREE · APPLIED IN YOUR CART
Order within — · ships today
Arrives Nov 12 – Nov 16 · free 2-day shipping over $150
Third Party
Tested & Verified
Secure Checkout
SSL Encrypted
Secure payments via
$54.99
Availability: In stock (can be backordered)
CHEMICAL BLOCK
The data your lab notebook needs.
Identity data for this material. Published lot reports, where one exists, are in the lab report library.
| FORM | Lyophilized Powder |
|---|---|
| PURITY | Per lot (see published lab report) |
| STORAGE | Lyophilized (powder): −20°C, away from light, unopened |
COMMON QUESTIONS
Everything researchers ask before ordering.
Compound information
Ipamorelin research data.
Synthetic pentapeptide ligand of the ghrelin receptor (GHS-R1a)
Ipamorelin is a synthetic pentapeptide amide with the sequence Aib-His-D-2Nal-D-Phe-Lys-NH2. It combines two non-proteinogenic residues, 2-aminoisobutyric acid (Aib) and 3-(2-naphthyl)-D-alanine (D-2Nal), with D-phenylalanine and a C-terminal lysinamide. The compound was developed in the late 1990s under the code NNC 26-0161 and carries the INN ipamorelin. Pharmacologically it is classed as an agonist of the ghrelin receptor, GHS-R1a.
Published work on ipamorelin spans peptide medicinal chemistry, receptor-binding and structure-activity papers in cell systems, and analytical chemistry. The references below are analytical papers: solid-phase extraction and liquid chromatography-mass spectrometry methods that list ipamorelin among their target peptides and report detection limits, extraction yield and precision. These are the same families of techniques used to confirm the identity of a synthetic peptide lot by its mass.
| Type | Synthetic linear pentapeptide amide |
|---|---|
| Sequence | Aib-His-D-2Nal-D-Phe-Lys-NH2 |
| Residues | 5 |
| Formula | C38H49N9O5 |
| Molecular weight | ~711.9 g/mol |
| CAS | 170851-70-4 |
| PubChem CID | 9831659 |
| Development code | NNC 26-0161 |
Lab reports
Lot reports for this product.
Each report names the lab, the lot, the test date and every assay run. Verify it on the lab's own portal.
No lot report is published for this product yet. Reports are added to the lab report library as testing completes.
Sources & references
Published literature.
Peer-reviewed papers on Ipamorelin, linked to PubMed.
- Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Kwok WH, Ho EN, Lau MY, et al.. Anal Bioanal Chem (2013). PubMed 23318763 → - Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine.
Semenistaya E, Zvereva I, Krotov G, et al.. Drug Test Anal (2016). PubMed 26472487 →
For in-vitro laboratory research use only by qualified researchers. Not for human or veterinary consumption. Not a drug, dietary supplement or cosmetic. These statements have not been evaluated by the FDA, and this product is not intended to diagnose, treat, cure or prevent any disease. This site does not provide medical advice. Literature listed above describes published research and is not a claim about this product. By purchasing, the buyer confirms the material is for laboratory research conducted by qualified personnel.
Research library
Further reading.
Identity, analysis and storage references from the Vortex research library.
Researchers also viewed
- 1 + 1
- 1 + 1
- 1 + 1
- 1 + 1
